Abstract
Allergic eye disease encompasses a spectrum of distinct but overlapping conditions. It includes acute seasonal allergic conjunctivitis (SAC), as well as the chronic conditions of perennial allergic conjunctivitis (PAC), atopic keratoconjunctivitis (AKC), and vernal keratoconjunctivitis (VKC). All the allergic eye diseases involve IgE-mediated type I hypersensitivity, leading to varying degrees of itching, redness, and tearing as common ocular surface symptoms in these patients. However, AKC and VKC are distinct from seasonal and perennial allergic disease in that the immune mechanisms in AKC and VKC are much more complex. In both conditions, a T-cell-mediated type IV hypersensitivity response, as well as activation of other inflammatory cytokine pathways, leads to more severe and prolonged conjunctival inflammation, as well as corneal involvement (Foster et al. Ophthalmology 1991;98(8):1190–1196). Here we will discuss several cases of allergic eye disease, including their diagnosis and management, with emphasis on distinguishing among the different types of allergic eye diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tsubota K, Takamura E, Hasegawa T, Kobayashi T. Detection by brush cytology of mast cells and eosinophils in allergic and vernal conjunctivitis. Cornea. 1991;10(6):525–31.
Montan PG, van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol. 1996;80(6):556–60.
Inada N, Shoji J, Kato H, Kiely S, Mulyanto SM. Clinical evaluation of total IgE in tears of patients with allergic conjunctivitis disease using a novel application of the immunochromatography method. Allergol Int. 2009;58(4):585–9. doi:10.2332/allergolint.09-OA-0101.
Bonini S, Bonini S, Lambiase A, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow up. Ophthalmology. 2000;107(6):1157–63. doi: S0161-6420(00)00092-0 [pii]
Pattnaik L, Acharya LA. comprehensive review on vernal keratoconjunctivitis with emphasis on proteomics. Life Sci. 2015;128:47–54. doi:10.1016/j.lfs.2015.01.040.
Bonini S, Lambiase A, Sgrulletta R, Bonini S. Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis. Curr Opin Allergy Clin Immunol. 2003;3(5):381–7. doi:10.1097/01.all.0000092610.76804.8a.
Donshik PC. Allergic conjunctivitis. Int Ophthalmol Clin. 1988;28(4):294–302.
Tuft SJ, Kemeny DM, Dart JK, Buckley RJ. Clinical features of atopic keratoconjunctivitis. Ophthalmology. 1991;98(2):150–8.
Lambiase A, Bonini S, Rasi G, Coassin M, Bruscolini A, Bonini S. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma. Arch Ophthalmol. 2003;121(5):615–20. doi:10.1001/archopht.121.5.615.
Gane J, Buckley R. Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2013;1(1):65–74. doi:10.1016/j.jaip.2012.07.001.
Neumann E, Gutmann MJ, Blumenkrantz N, Michaelson IC. A review of four hundred cases of vernal conjunctivitis. Am J Ophthalmol. 1959;47(2):166–72.
Cameron JA. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology. 1995;102(6):985–93.
Cameron JA, Antonios SR, Badr IA. Excimer laser phototherapeutic keratectomy for shield ulcers and corneal plaques in vernal keratoconjunctivitis. J Refract Surg. 1995;11(1):31–5.
Holsclaw DS, Whitcher JP, Wong IG, Margolis TP. Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis. Am J Ophthalmol. 1996;121(3):243–9.
Saini JS, Gupta A, Pandey SK, Gupta V, Gupta P. Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis. Acta Ophthalmol Scand. 1999;77(5):515–8.
Bielory B, Bielory L. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin North Am. 2010;30(3):323–36. doi:10.1016/j.iac.2010.06.004.
Bremond-Gignac D, Nischal KK, Mortemousque B, Gajdosova E, Granet DB, Chiambaretta F. Atopic keratoconjunctivitis in children: clinical features and diagnosis. Ophthalmology. 2015;123(2):435–7. doi: S0161-6420(15)00703-4 [pii]
Power WJ, Tugal-Tutkun I, Foster CS. Long-term follow-up of patients with atopic keratoconjunctivitis. Ophthalmology. 1998;105(4):637–42. doi: S0161-6420(98)94017-9 [pii]
Hogan MJ. Atopic keratoconjunctivitis. Am J Ophthalmol. 1953;36(7 1):937–47.
Guglielmetti S, Dart JK, Calder V. Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2010;10(5):478–85. doi:10.1097/ACI.0b013e32833e16e4.
Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: a review. J Am Acad Dermatol. 2014;70(3):569–75. doi:10.1016/j.jaad.2013.10.036.
Foster CS, Calonge M. Atopic keratoconjunctivitis. Ophthalmology. 1990;97(8):992–1000.
Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol. 2000;84(8):834–6.
Rahi A, Davies P, Ruben M, Lobascher D, Menon J. Keratoconus and coexisting atopic disease. Br J Ophthalmol. 1977;61(12):761–4.
Harrison RJ, Klouda PT, Easty DL, Manku M, Charles J, Stewart CM. Association between keratoconus and atopy. Br J Ophthalmol. 1989;73(10):816–22.
Yoneda K, Okamoto H, Wada Y, et al. Atopic retinal detachment. Report of four cases and a review of the literature. Br J Dermatol. 1995;133(4):586–91.
Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 2010;24(3):317–28. doi:10.1111/j.1468-3083.2009.03415.x.
Attas-Fox L, Barkana Y, Iskhakov V, et al. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study. Curr Eye Res. 2008;33(7):545–9. doi:10.1080/02713680802149115.
Rikkers SM, Holland GN, Drayton GE, Michel FK, Torres MF, Takahashi S. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol. 2003;135(3):297–302. doi: S0002939402019827 [pii]
Akpek EK, Dart JK, Watson S, et al. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology. 2004;111(3):476–82. doi:10.1016/j.ophtha.2003.05.035.
Daniell M, Constantinou M, Vu HT, Taylor HR. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Ophthalmol. 2006;90(4):461–4. doi: 90/4/461 [pii]
Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol. 2011;11(5):477–82. doi:10.1097/ACI.0b013e32834a9652.
Taille C, Doan S, Neukirch C, Aubier M. Omalizumab for severe atopic keratoconjunctivitis. BMJ Case Rep. 2010;2010:pii: bcr0420102919. doi:10.1136/bcr.04.2010.2919.
Daniell MD, Dart JK, Lightman S. Use of cyclosporin in the treatment of steroid resistant post-keratoplasty atopic sclerokeratitis. Br J Ophthalmol. 2001;85(1):91–2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Paik, J., Batta, P. (2018). Management of Ocular Surface Allergic Diseases. In: Djalilian, A. (eds) Ocular Surface Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-15823-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-15823-5_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15822-8
Online ISBN: 978-3-319-15823-5
eBook Packages: MedicineMedicine (R0)